Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Digital Health Literacy and Oocyte Cryopreservation Among Women With Gynecological Cancer

8. juli 2026 opdateret af: Eman Atef Elsokary, Benha University

Digital Health Literacy and Oocyte Cryopreservation: Perspectives of Newly Diagnosed Gynecological Cancer Women

This study evaluated a digital health literacy education intervention related to oocyte cryopreservation among newly diagnosed women with gynecological cancer. A quasi-experimental single-group pre-post design was used at the Outpatient Clinics of the Oncology Center, Mansoura University Hospital, Egypt. A purposive sample of 158 women participated. Outcomes were measured before and after the intervention and included knowledge about oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The intervention used videos, images, WhatsApp, Zoom, Microsoft Teams, PowerPoint slides, short text messages, simple Arabic-language educational materials, and follow-up through phone or social media when needed. Outcomes were reassessed at the end of week 4.

Studieoversigt

Status

Afsluttet

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Newly diagnosed women with gynecological cancer may face fertility-related concerns before starting cancer treatment. This study assessed whether a digital health literacy education intervention related to oocyte cryopreservation could improve women's knowledge, attitudes, and decisional conflict.

The study used a quasi-experimental single-group pre-post design. It was conducted at the Outpatient Clinics of the Oncology Center at Mansoura University Hospital, Dakahlia Governorate, Egypt. The study included 158 newly diagnosed women with gynecological cancer selected using purposive sampling.

Eligible participants were women aged 18 to 45 years who were newly diagnosed with gynecological cancer, had not received cancer treatment, had not received cryopreservation instructions before, and had access to a smartphone, internet connection, and social media. Women who had received chemotherapy, radiotherapy, or hormonal therapy, or who had learning difficulties such as dementia or vision impairment, were excluded.

were women Baseline data were collected using a structured interview questionnaire and study tools assessing knowledge about gynecological cancer and oocyte cryopreservation, attitudes toward oocyte cryopreservation, and decisional conflict. The digital health literacy intervention was delivered using videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals and animations, simple Arabic language, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages, benefits, and process steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition.

Four sessions were delivered, with 20 women per group. Each session was held three days per week on Sunday, Tuesday, and Thursday and lasted 30 to 45 minutes. Follow-up was conducted by phone or social media as needed to reinforce planning and address barriers. Outcomes were reassessed at the end of week 4 using the same instruments.

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

158

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiesteder

  • Egypten
    • Dakahlia Governorate
      • Al Mansurah, Dakahlia Governorate, Egypten
        • Oncology Center, Mansoura University Hospital

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria:

  • Newly diagnosed women with gynecological cancers who had not received any treatment.
  • Women of reproductive age, 18-45 years.
  • Women with gynecological cancers who had not received cryopreservation instructions before.
  • Women who had a smartphone, internet connection, could use social media, and had access to the internet through their phone.

Exclusion Criteria:

  • Women with gynecological cancer who had received cancer treatment, including chemotherapy, radiotherapy, or hormonal therapy.
  • Women diagnosed with learning difficulties, such as dementia or vision impairment.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Digital Health Literacy Intervention
Participants received a digital health literacy education intervention related to oocyte cryopreservation. Outcomes were measured before and after the intervention.
Adfærdsmæssigt: Digital Health Literacy Education Intervention
The intervention included videos, visually engaging images, WhatsApp groups, Zoom and Microsoft Teams meetings, PowerPoint slides, short text messages, interactive visuals/animations, simple Arabic-language educational materials, and instructive pictures. The educational content covered general information about gynecological cancer and fertility, fertility-preservation options, and detailed information about oocyte cryopreservation, including definition, indications, advantages/benefits, and process/steps. Content also included embryo cryopreservation, ovarian tissue cryopreservation, fertility-sparing surgery, and ovarian transposition. Follow-up was conducted by phone or social media as needed.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Change in Knowledge Regarding Oocyte Cryopreservation
Tidsramme: Pre-intervention and end of week 4
Knowledge regarding oocyte cryopreservation was assessed using the Oocyte Cryopreservation Knowledge Questionnaire. The questionnaire included 20 multiple-choice questions covering general information about gynecological cancer and fertility, fertility preservation options, and oocyte cryopreservation. Each correct answer was scored 1 and each incorrect or "don't know" answer was scored 0. The total score ranged from 0 to 20, with higher scores indicating higher knowledge. Scores of 60% or higher were classified as satisfactory knowledge.
Pre-intervention and end of week 4
Change in Attitude Toward Oocyte Cryopreservation
Tidsramme: Pre-intervention and end of week 4
Attitude toward oocyte cryopreservation was assessed using an attitude scale developed by the researchers after reviewing the literature. The scale included 15 statements: 11 positive statements and 4 negative statements. Responses were scored using a three-point Likert scale: agree = 2, uncertain = 1, and disagree = 0. Negatively worded items were reverse scored. The total score ranged from 0 to 30, with higher scores indicating a more positive attitude toward oocyte cryopreservation. Scores of 70% or higher were classified as positive attitude.
Pre-intervention and end of week 4
Change in Decisional Conflict Regarding Oocyte Cryopreservation
Tidsramme: Pre-intervention and end of week 4
Decisional conflict regarding oocyte cryopreservation was assessed using the 16-item Decisional Conflict Scale. Items were organized into five domains related to feeling informed, value clarification, support, uncertainty, and effective decision-making. Responses were scored on a five-point scale from strongly agree to strongly disagree. The total score ranged from 0 to 100, with higher scores indicating greater decisional conflict. Scores less than 25 indicated low decisional conflict, scores between 25 and 37.5 indicated moderate decisional conflict, and scores above 37.5 indicated high decisional conflict.
Pre-intervention and end of week 4

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

Benha University

Samarbejdspartnere

Mansoura University

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. september 2025

Primær færdiggørelse (Faktiske)

30. marts 2026

Studieafslutning (Faktiske)

30. marts 2026

Datoer for studieregistrering

Først indsendt

8. juli 2026

Først indsendt, der opfyldte QC-kriterier

8. juli 2026

Først opslået (Faktiske)

14. juli 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

14. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

8. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Nøgleord

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • IRB00000844

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

JA

IPD-planbeskrivelse

Data supporting the study findings will be available upon reasonable request from the corresponding author.

IPD-delingstidsramme

Available upon reasonable request after publication.

IPD-delingsadgangskriterier

Researchers may request access to the data from the corresponding author.

IPD-deling Understøttende informationstype

  • STUDY_PROTOCOL

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Digital Health Literacy Education Intervention

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Panama

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

3
Abonner